| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 712 | 2021 |
| Clostridioides (Clostridium) difficile infection burden in Japan: a multicenter prospective study H Kato, M Senoh, H Honda, T Fukuda, Y Tagashira, H Horiuchi, H Chiba, ... Anaerobe 60, 102011, 2019 | 66 | 2019 |
| Multi-institution case–control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in Japan M Takahashi, N Mori, S Bito BMJ open 4 (9), e005665, 2014 | 56 | 2014 |
| DOCK2 is involved in the host genetics and biology of severe COVID-19 H Namkoong, R Edahiro, T Takano, H Nishihara, Y Shirai, K Sonehara, ... Nature 609 (7928), 754-760, 2022 | 53 | 2022 |
| Spread of a large plasmid carrying the cpe gene and the tcp locus amongst Clostridium perfringens isolates from nosocomial outbreaks and sporadic cases of gastroenteritis in a … S Kobayashi, A Wada, S Shibasaki, M Annaka, H Higuchi, K Adachi, ... Epidemiology & Infection 137 (1), 108-113, 2009 | 38 | 2009 |
| Incorrect diagnosis of Clostridium difficile infection in a university hospital in Japan N Mori, S Yoshizawa, T Saga, Y Ishii, H Murakami, M Iwata, DA Collins, ... Journal of Infection and Chemotherapy 21 (10), 718-722, 2015 | 36 | 2015 |
| Endogenous IL-17 as a factor determining the severity of Clostridium difficile infection in mice T Nakagawa, N Mori, C Kajiwara, S Kimura, Y Akasaka, Y Ishii, T Saji, ... Journal of medical microbiology 65 (8), 821-827, 2016 | 34 | 2016 |
| A peptide based on homologous sequences of the β-barrel assembly machinery component BamD potentiates antibiotic susceptibility of Pseudomonas aeruginosa N Mori, Y Ishii, K Tateda, S Kimura, Y Kouyama, H Inoko, S Mitsunaga, ... Journal of Antimicrobial Chemotherapy 67 (9), 2173-2181, 2012 | 32 | 2012 |
| Characteristics and immunological roles of surface layer proteins in Clostridium difficile N Mori, T Takahashi Annals of laboratory medicine 38 (3), 189, 2018 | 29 | 2018 |
| Clinical characteristics and risk factors for community-acquired Clostridium difficile infection: A retrospective, case-control study in a tertiary care hospital in Japan N Mori, Y Aoki Journal of Infection and Chemotherapy 21 (12), 864-867, 2015 | 26 | 2015 |
| Regression of idiopathic thrombocytopenic purpura after endoscopic mucosal resection of gastric mucosa associated lymphoid tissue lymphoma M Noda, N Mori, K Nomura, K Kojima, S Mitsufuji, I Yamane, S Misawa, ... Gut 53 (11), 1698-1700, 2004 | 26 | 2004 |
| Regression of idiopathic thrombocytopenic purpura after endoscopic mucosal resection of gastric mucosa associated lymphoid tissue lymphoma M Noda, N Mori, K Nomura, K Kojima, S Mitsufuji, I Yamane, S Misawa, ... Gut 53 (11), 1698-1700, 2004 | 26 | 2004 |
| Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: meta-analysis of randomized controlled trials Y Igarashi, S Tashiro, Y Enoki, K Taguchi, K Matsumoto, H Ohge, ... Journal of infection and chemotherapy 24 (11), 907-914, 2018 | 25 | 2018 |
| Risk factors of catheter-related bloodstream infection caused by Bacillus cereus: Case-control study in 8 teaching hospitals in Japan S Kutsuna, K Hayakawa, K Kita, Y Katanami, N Imakita, K Kasahara, ... American Journal of Infection Control 45 (11), 1281-1283, 2017 | 24 | 2017 |
| Japanese clinical practice guidelines for management of Clostridioides (Clostridium) difficile infection H Kunishima, H Ohge, H Suzuki, A Nakamura, K Matsumoto, H Mikamo, ... Journal of Infection and Chemotherapy 28 (8), 1045-1083, 2022 | 22 | 2022 |
| Evidence of intravenous immunoglobulin as a critical supportive therapy against Clostridium difficile toxin-mediated lethality in mice T Saito, S Kimura, K Tateda, N Mori, N Hosono, K Hayakawa, Y Akasaka, ... Journal of antimicrobial chemotherapy 66 (5), 1096-1099, 2011 | 20 | 2011 |
| Oral fidaxomicin versus vancomycin for the treatment of Clostridioides difficile infection: A systematic review and meta-analysis of randomized controlled trials S Tashiro, T Mihara, M Sasaki, C Shimamura, R Shimamura, S Suzuki, ... Journal of Infection and Chemotherapy 28 (11), 1536-1545, 2022 | 18 | 2022 |
| Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID‐19: Integrative analysis from the Japan COVID‐19 task force T Fukushima, S Chubachi, H Namkoong, T Asakura, H Tanaka, H Lee, ... Diabetes, Obesity and Metabolism 25 (1), 144-155, 2023 | 15 | 2023 |
| Multisystem inflammatory syndrome in adults after mild SARS-CoV-2 infection, Japan Y Yamada, K Fujinami, T Eguchi, H Takefuji, N Mori Emerging Infectious Diseases 27 (6), 1740, 2021 | 15 | 2021 |
| Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan H Namkoong, R Edahiro, K Fukunaga, Y Shirai, K Sonehara, H Tanaka, ... Medrxiv, 2021.05. 17.21256513, 2021 | 15 | 2021 |
